Martin-Oliva et al., Cancer Res 2006
(Cell Transformation, Neoplastic...) :
Inhibition of PARP also affected activator protein-1 (AP-1) activation but not nuclear factor-kappaB (NF-kappaB)
García et al., Ann Rheum Dis 2008
(Arthritis, Rheumatoid) :
PARP inhibition reduced TNF induced JNK phosphorylation and AP-1 and NF kappaB binding activities were partially impaired by treatment with PARP inhibitors or by PARP-1 knockdown
Li et al., Neurourol Urodyn 2010
(Diabetes Complications...) :
The aim of this study was to investigate whether the activation of PARP and subsequent activation of c-Jun N-terminal kinase (JNK) and the mitochondrial apoptotic pathway are involved in the development of diabetic cystopathy